Loading clinical trials...

Pharmacogenomics Registry to Assess Clinical Utility | Clinical Trials | Clareo Health

UNKNOWNNCT02374840

Pharmacogenomics Registry to Assess Clinical Utility

The PREACT Registry aims to see whether data from Pharmacogenomic Testing (PGx) can help healthcare providers manage patient medication regimens and assess if the testing has an effect on reducing med...

Lead sponsor: Companion Dx Reference Lab, LLC•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Study Coordinator

CONTACT

preact@companiondxlab.com

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment340,778

Start date—

Last updatedJul 22, 2015

Condition

Drug Side Effects

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 22, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions